ctDNA Clearance Linked to Outcomes in Resectable Lung Cancer in NeoCOAST-2
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
NeoCOAST-2 examines whether clearance of circulating tumour DNA is associated with treatment outcomes among patients with resectable lung cancer, assessing ctDNA as a potential marker of response.
Continue in the app — vote & join in ➔Source: Nature News · via ahirlevel.hu